Leading Companies in Fill Finish Manufacturing

The global fill finish manufacturing market is projected to reach USD 28.14 billion by 2030 from USD 18.36 billion in 2025, at a CAGR of 8.9% from 2025 to 2030. The growth of the fill finish manufacturing market can be credited to the expansion of the GLP-1, biosimilars, and vaccine pipeline, which is driving volumes for biologics fill finish, and Annex-1 compliance requirements are driving equipment upgradation.

Several key players in the fill finish manufacturing industry with a strong global footprint include Syntegon Technology GmbH (Germany), I.M.A S.P.A. (Italy), BD & Co. (US), West Pharmaceutical Services, Inc. (US), Gerresheimer AG (Germany), AptarGroup, Inc. (US), Datwyler Holding Inc. (Belgium), Danaher (US), Stevanato Group S.p.A. (Italy), OPTIMA (Germany), Bausch+Ströbel (Germany), Groninger & Co. GmbH (Germany), SGD PHARMA (France), SCHOTT (Germany), Nipro Corporation (Japan), Bausch Advanced Technology Group (US), and Maquinaria Industrial Dara, SL (Spain). Companies operating in this sector are employing various growth strategies to strengthen their international presence and reinforce market positions. For instance, companies like West Pharmaceutical Services and Syntegon Technology GmbH are expanding manufacturing capabilities through facility investments and acquisitions and forming long-term collaborations with pharmaceutical firms to secure a strong position across clinical and commercial production.

To know about the assumptions considered for the study download the pdf brochure

West Pharmaceutical Services, Inc. (US):

West Pharmaceutical Services Inc. is a global leader in injectable drug delivery solutions, with a strong focus on fill finish manufacturing. The company offers a comprehensive range of products, including pre-fillable syringes, vials, cartridges, and closure systems, all designed to maintain drug integrity and ensure user safety. West emphasizes innovation, investing heavily in R&D to develop advanced technologies that align with industry trends and regulatory demands. Its growth strategy also includes expanding market presence through strategic partnerships and acquisitions. By prioritizing customer-focused solutions, West continues to enhance its product offerings and strengthen its role in the pharmaceutical and healthcare sectors. For instance, in January 2025, West Pharmaceutical Services, Inc. (West) launched the PLASCAP closure, which is a metal-free polypropylene cap with an integrated stopper. This one-step press-fit solution for vial closure is offered in ready-to-use, validated formats compatible with vials. In November 2024, West also announced continued expansion of the Dublin manufacturing facility, while in May 2024, the company announced expansion in South Korea with a new office facility & expanded warehouse capacity.

BD & Co. (US):

BD & Co. (Becton, Dickinson and Company) is a key player in the fill finish manufacturing industry, offering a broad portfolio of syringes and drug delivery systems tailored for pharmaceutical and biotech companies. The company focuses on innovation, investing significantly in R&D to develop advanced technologies that improve drug delivery precision, safety, and user experience. BD & Co. also emphasizes global expansion, utilizing its international presence to meet varying regulatory standards and customer demands. Its growth strategy includes forming strategic partnerships and pursuing acquisitions, enabling BD & Co. to diversify its offerings, enter new markets, and solidify its position as a leading provider in the sector. For instance, in September 2024, BD & Co. announced the expansion of the BD & Co. Neopak Glass Prefillable Syringe platform with the commercial release of the BD & Co. Neopak XtraFlow Glass Prefillable Syringe. It is an 8 mm needle and a thinner-walled cannula. The new design enables easier subcutaneous delivery of high-viscosity biologics by reducing injection force and time.

Market Ranking:

The fill-finish manufacturing market is highly competitive, with five major players: Syntegon Technology GmbH (Germany), I.M.A. S.P.A. (Italy), BD & Co. (US), West Pharmaceutical Services, Inc. (US), and Gerresheimer AG (Germany). These companies collectively account for a significant portion of the total market. These companies maintain their leading positions through strategic investments, regulatory advancements, technological innovation, and global partnerships.

Syntegon Technology GmbH (Germany) is a leading provider of process and packaging technology for the pharmaceutical industry. The company offers advanced fill finish solutions, including aseptic filling lines and inspection systems. Syntegon focuses on innovation, digitalization, and sustainability, enhancing production efficiency and compliance with global regulatory standards.

I.M.A. S.P.A. (Italy) is a global leader in pharmaceutical processing and packaging machinery. The company provides automated fill finish solutions, including vial filling, capping, and labelling systems. Known for innovation and quality, I.M.A. emphasizes modular design and customization, catering to diverse client needs across regulated markets.

BD & Co. (US) is a major player in injectable drug delivery systems, offering pre-fillable syringes, vials, and related solutions. The company invests heavily in R&D to improve safety and precision in drug administration. BD & Co. also focuses on strategic partnerships and international expansion to strengthen its market leadership.

Stevanato Group is expanding its presence in the fill-finish market with integrated solutions combining drug containment and delivery systems. It is focusing on modular, automated lines for small-batch and high-value biologics, including mRNA and cell therapies. The company is also advancing sustainability by actively exploring PFAS-free consumables.

West Pharmaceutical Services, Inc. (US) delivers innovative packaging and delivery systems for injectable drugs. Its fill finish solutions include pre-fillable systems and closures, ensuring sterility and patient safety. West prioritizes R&D, customer-centric innovation, and strategic collaborations to expand its global footprint and meet evolving industry and regulatory demands.

Gerresheimer AG (Germany) specializes in glass and plastic primary packaging products for the pharmaceutical sector. Its fill finish solutions include high-quality syringes, vials, and cartridges. With a focus on precision manufacturing, sustainability, and digital innovation, Gerresheimer strengthens its global presence through expansion and partnerships.

The remaining fill finish manufacturing market is occupied by regional and emerging biotech companies. These players are gaining ground through partnerships, collaborations, and technological innovation. Market shifts are driven by advances in pharmaceutical contract manufacturing, changing regulatory landscapes, and growing demand for non-invasive, personalized medicine. To stay competitive, companies must emphasize innovation, scalability, and responsiveness to unmet needs in fields like customized solutions.

Related Reports:

Fill Finish Manufacturing Market by Product ((Consumables (PFS (Glass), Plunger Stopper), Vial (RTU, Polymer), Vial Stoppers (RTU), Cartridge, Cell Therapy Bags), Instruments (Integrated, Automated)), Fill Finish Service, End User - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com